BRKR · CIK 1109354
What Bruker Corporation told the SEC could break it.
Bruker's exposures sit on both sides of its scientific-instruments business. On demand, a substantial share of its sales go to non-profit and government customers whose purchasing depends on government support for scientific research, so any pullback in that funding directly dents its market. On supply, its production is notably concentrated and fragile: many products are developed and built at single locations with limited alternate facilities, and it buys critical components — detectors, power supplies, and superconducting magnets/electronics — from sole or limited-source suppliers, where a shortage could materially hurt revenue and margins. Compounding that, new U.S. and reciprocal tariffs have already had a material adverse effect, raising cost of goods sold and compressing its 2025 gross margin.
4 self-disclosed vulnerabilities, pulled from its own filings, each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Customer concentration
- government/academic customers dependent on research fundingmedium
A substantial portion of Bruker's sales are to non-profit and government entities dependent on government support for scientific research; declines in that support reduce their ability to buy Bruker's products.
“In addition, a substantial portion of our sales are to non-profit and government entities, which are dependent on government support for scientific research. Any decline in this support could decrease the ability of these customers to purchase our products.”
SEC filing →As of 2026
Geographic concentration
- single-location product manufacturing (limited alternate facilities)medium
Many Bruker products are developed and manufactured at single locations with limited alternate facilities, so a disruption at one site could halt specific product lines.
“Many of our products are developed and manufactured at single locations, with limited alternate facilities.”
SEC filing →As of 2026
Regulatory & policy
- U.S. and reciprocal tariffs (material adverse effect)medium
New U.S. and reciprocal tariffs have had a material adverse effect on Bruker, raising cost of goods sold and compressing 2025 gross margin (alongside FX headwinds).
“New U.S. and reciprocal tariffs that have been imposed, and remain subject to potential change and other uncertainties, including as a result of the recent U.S. Supreme Court decision, have had a material adverse effect on our business, results of operations and financial condition, and may continue to do so in the foreseeable future;”
Sole-source dependency
- detectors, power supplies, superconducting magnets (sole/limited source)medium
Bruker's BSI CALID buys detectors and power supplies from sole or limited-source suppliers, and superconducting magnets/electronics depend on a few large manufacturers (EMS, high-temperature-superconductor suppliers); shortages could materially hurt revenue/margins.
“As an example, BSI CALID purchases detectors and power supplies from sole or limited source suppliers. Additionally, our superconducting magnets or our electronics are partially dependent on cooperation from larger manufacturers like Electronic Manufacturing Services or High Temperature Superconductors suppliers.”
SEC filing →As of 2026
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings, including ones disclosed by the other side, which is how the non-obvious ones come to light.
Its customers
“we rely on NanoString (now Bruker Spatial Biology as a result of Bruker Corporation's asset acquisition of NanoString) for certain components and raw materials for the Prosigna test and nCounter service kits.”
Cited →
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch